Robert Ang - Mar 1, 2023 Form 4 Insider Report for Vor Biopharma Inc. (VOR)

Role
President and CEO, Director
Signature
/s/ Katie Kazem, Attorney-in-Fact
Stock symbol
VOR
Transactions as of
Mar 1, 2023
Transactions value $
-$69,740
Form type
4
Date filed
3/2/2023, 05:39 PM
Previous filing
Feb 8, 2023
Next filing
May 10, 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VOR Common Stock Tax liability -$69.7K -12.7K -1.77% $5.51 701K Mar 1, 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares were withheld to satisfy the Reporting Person's tax withholding obligations in connection with the settlement of restricted stock units ("RSUs").

Remarks:

Exhibit List - Exhibit 24 - Power of Attorney